These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9083301)

  • 1. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer.
    Roman LD; Muderspach LI; Stein SM; Laifer-Narin S; Groshen S; Morrow CP
    Obstet Gynecol; 1997 Apr; 89(4):493-500. PubMed ID: 9083301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin.
    Valentin L
    Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):63-72. PubMed ID: 9076424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler.
    Carter J; Saltzman A; Hartenbach E; Fowler J; Carson L; Twiggs LB
    Obstet Gynecol; 1994 Jan; 83(1):125-30. PubMed ID: 8272293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer.
    Buckshee K; Temsu I; Bhatla N; Deka D
    Int J Gynaecol Obstet; 1998 Apr; 61(1):51-7. PubMed ID: 9622173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography.
    Franchi M; Beretta P; Ghezzi F; Zanaboni F; Goddi A; Salvatore S
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):734-9. PubMed ID: 7572110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
    Varras M
    Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?
    Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):215-25. PubMed ID: 17201017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass.
    Mousavi AS; Borna S; Moeinoddini S
    Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors.
    Valentin L; Sladkevicius P; Marsàl K
    Obstet Gynecol; 1994 Mar; 83(3):425-33. PubMed ID: 8127537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
    Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
    AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Nov; 14(5):338-47. PubMed ID: 10623994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment evaluation of adnexal tumors predicting ovarian cancer.
    Kobal B; Rakar S; Ribic-Pucelj M; Tomazevic T; Zaletel-Kragelj L
    Int J Gynecol Cancer; 1999 Nov; 9(6):481-486. PubMed ID: 11240815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis.
    Kinkel K; Lu Y; Mehdizade A; Pelte MF; Hricak H
    Radiology; 2005 Jul; 236(1):85-94. PubMed ID: 15955864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with a pelvic mass: indicators of malignancy.
    Balbi GC; Musone R; Menditto A; Balbi F; Corcioni C; Calabria G; Maciariello C; Balbi C
    Eur J Gynaecol Oncol; 2001; 22(6):459-62. PubMed ID: 11874083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.
    Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB
    Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.